Literature DB >> 21593771

Activation of transient receptor potential vanilloid-3 inhibits human hair growth.

István Borbíró1, Erika Lisztes, Balázs I Tóth, Gabriella Czifra, Attila Oláh, Attila G Szöllosi, Norbert Szentandrássy, Péter P Nánási, Zoltán Péter, Ralf Paus, László Kovács, Tamás Bíró.   

Abstract

In the current study, we aimed at identifying the functional role of transient receptor potential vanilloid-3 (TRPV3) ion channel in the regulation of human hair growth. Using human organ-cultured hair follicles (HFs) and cultures of human outer root sheath (ORS) keratinocytes, we provide the first evidence that activation of TRPV3 inhibits human hair growth. TRPV3 immunoreactivity was confined to epithelial compartments of the human HF, mainly to the ORS. In organ culture, TRPV3 activation by plant-derived (e.g., eugenol, 10-1,000 μM) or synthetic (e.g., 2-aminoethoxydiphenyl borate, 1-300 μM) agonists resulted in a dose-dependent inhibition of hair shaft elongation, suppression of proliferation, and induction of apoptosis and premature HF regression (catagen). Human ORS keratinocytes also expressed functional TRPV3, whose stimulation induced membrane currents, elevated intracellular calcium concentration, inhibited proliferation, and induced apoptosis. Of great importance, these effects on ORS keratinocytes were all mediated by TRPV3, as small interfering RNA-mediated silencing of TRPV3 effectively abrogated the cellular actions of the above agonists. These findings collectively support the concept that TRPV3 signaling is a significant player in human hair growth control. Therefore, TRPV3 and the related intracellular signaling mechanism might function as a promising target for pharmacological manipulations of clinically relevant hair growth disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593771     DOI: 10.1038/jid.2011.122

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  35 in total

1.  Exome sequencing reveals mutations in TRPV3 as a cause of Olmsted syndrome.

Authors:  Zhimiao Lin; Quan Chen; Mingyang Lee; Xu Cao; Jie Zhang; Donglai Ma; Long Chen; Xiaoping Hu; Huijun Wang; Xiaowen Wang; Peng Zhang; Xuanzhu Liu; Liping Guan; Yiquan Tang; Haizhen Yang; Ping Tu; Dingfang Bu; Xuejun Zhu; KeWei Wang; Ruoyu Li; Yong Yang
Journal:  Am J Hum Genet       Date:  2012-03-09       Impact factor: 11.025

Review 2.  TRP channels in the skin.

Authors:  Balázs I Tóth; Attila Oláh; Attila Gábor Szöllősi; Tamás Bíró
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 3.  TRPV3: time to decipher a poorly understood family member!

Authors:  Bernd Nilius; Tamás Bíró; Grzegorz Owsianik
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

Review 4.  Transient receptor potential (TRP) channels: a clinical perspective.

Authors:  Yosuke Kaneko; Arpad Szallasi
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

5.  Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes.

Authors:  Attila Oláh; Balázs I Tóth; István Borbíró; Koji Sugawara; Attila G Szöllõsi; Gabriella Czifra; Balázs Pál; Lídia Ambrus; Jennifer Kloepper; Emanuela Camera; Matteo Ludovici; Mauro Picardo; Thomas Voets; Christos C Zouboulis; Ralf Paus; Tamás Bíró
Journal:  J Clin Invest       Date:  2014-07-25       Impact factor: 14.808

Review 6.  Defective channels lead to an impaired skin barrier.

Authors:  Diana C Blaydon; David P Kelsell
Journal:  J Cell Sci       Date:  2014-09-01       Impact factor: 5.285

7.  Olmsted syndrome caused by a homozygous recessive mutation in TRPV3.

Authors:  Ori Eytan; Dana Fuchs-Telem; Baruch Mevorach; Margarita Indelman; Reuven Bergman; Ofer Sarig; Ilan Goldberg; Noam Adir; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2014-01-24       Impact factor: 8.551

8.  Camphor white oil induces tumor regression through cytotoxic T cell-dependent mechanisms.

Authors:  Yalda Moayedi; Sophie A Greenberg; Blair A Jenkins; Kara L Marshall; Lina V Dimitrov; Aislyn M Nelson; David M Owens; Ellen A Lumpkin
Journal:  Mol Carcinog       Date:  2019-01-20       Impact factor: 4.784

9.  COX-2-selective inhibitors celecoxib and deracoxib modulate transient receptor potential vanilloid 3 channels.

Authors:  Stefan Spyra; Anne Meisner; Michael Schaefer; Kerstin Hill
Journal:  Br J Pharmacol       Date:  2017-06-29       Impact factor: 8.739

10.  Targeting TRPV3 for the Development of Novel Analgesics.

Authors:  Susan M Huang; Man-Kyo Chung
Journal:  Open Pain J       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.